NantHealth, Inc. Quarterly Debt-to-equity in % from Q1 2017 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NantHealth, Inc. quarterly Debt-to-equity history and growth rate from Q1 2017 to Q3 2023.
  • NantHealth, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -166 %, a 16% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -166 +31.6 +16% Sep 30, 2023
Q2 2023 -171 +42.7 +20% Jun 30, 2023
Q1 2023 -177 +55 +23.7% Mar 31, 2023
Q4 2022 -185 +59 +24.2% Dec 31, 2022
Q3 2022 -197 +60.4 +23.5% Sep 30, 2022
Q2 2022 -213 +60.3 +22% Jun 30, 2022
Q1 2022 -232 +61.4 +20.9% Mar 31, 2022
Q4 2021 -244 +132 +35.2% Dec 31, 2021
Q3 2021 -258 +200 +43.7% Sep 30, 2021
Q2 2021 -274 +291 +51.5% Jun 30, 2021
Q1 2021 -294 +446 +60.3% Mar 31, 2021
Q4 2020 -376 +453 +54.7% Dec 31, 2020
Q3 2020 -458 +876 +65.7% Sep 30, 2020
Q2 2020 -565 -16.6K -104% Jun 30, 2020
Q1 2020 -740 -1.34K -223% Mar 31, 2020
Q4 2019 -829 -1.12K -388% Dec 31, 2019
Q3 2019 -1.33K -1.52K -819% Sep 30, 2019
Q2 2019 16K +15.9K +11046% Jun 30, 2019
Q1 2019 600 +481 +404% Mar 31, 2019
Q4 2018 288 +190 +194% Dec 31, 2018
Q3 2018 186 +103 +124% Sep 30, 2018
Q2 2018 144 +78.9 +121% Jun 30, 2018
Q1 2018 119 +65.7 +123% Mar 31, 2018
Q4 2017 98 Dec 31, 2017
Q3 2017 82.7 Sep 30, 2017
Q2 2017 65.1 Jun 30, 2017
Q1 2017 53.5 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.